We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

241:HKEXCX Technology Corporation Analysis

Data as of 2026-06-21 - not real-time

¥453.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Gendai Agency trades at a PE of 10.73, well below the advertising industry average of 16.65, indicating a clear valuation discount. The stock offers a 5.74% dividend yield with a payout ratio of 56.8%, supported by robust cash holdings (≈¥3.2 bn) and modest debt (¥0.59 bn). Technical signals are mixed: the price sits above the 20‑day SMA (¥447) but below the 50‑day (¥459) and 200‑day (¥462) averages, and while the MACD histogram is positive, the overall trend remains bearish with decreasing volume. Volatility over the past 30 days is about 13.3% and beta is low at 0.23, suggesting limited price swings relative to the market. A discounted cash flow model values the company at roughly ¥903, nearly double the current market price of ¥453, implying substantial upside potential if fundamentals hold steady.
Given the negative revenue growth (-8.1%) and modest operating margins, the stock leans more toward a value profile rather than growth. The high dividend yield and low leverage provide a cushion, but the bearish technical backdrop and declining volume warrant a cautious approach in the short term. Over the medium to long horizon, the valuation gap and dividend sustainability could drive price appreciation, provided the company stabilizes its top‑line performance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Current price near resistance at ¥458
  • Bearish technical trend despite bullish MACD histogram
  • High dividend yield provides income while awaiting upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount (DCF fair value ~¥903 vs market ¥453)
  • Sustainable dividend with strong cash position
  • Low beta and modest volatility support stability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Potential upside of ~100% if DCF valuation materializes
  • Consistent dividend income and low leverage
  • Defensive profile in a low‑beta, low‑currency‑risk environment

Key Metrics & Analysis

Financial Health

Revenue Growth-8.10%
Profit Margin6.28%
P/E Ratio10.7
ROE11.69%
ROA7.58%
Debt/Equity15.09
P/B Ratio1.3
Op. Cash Flow¥673.0M
Free Cash Flow¥554.1M
Industry P/E16.7

Technical Analysis

TrendBearish
RSI52.9
Support¥438.00
Resistance¥458.00
MA 20¥447.20
MA 50¥458.98
MA 200¥461.71
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value¥902.83
GradeUndervalued
TypeValue
Dividend Yield5.74%

Risk Assessment

Beta0.23
Volatility13.32%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.